13F Filings History of QCM Cayman, Ltd.

13F snapshot Latest parsed holdings, value, and filing-period context. 1 signal
Form 13F summary
  • QCM Cayman, Ltd. Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • QCM Cayman, Ltd. reported 12 equity holdings with a total reported market value of $3,632,666 for Q3 2024. Top reported holdings included SQQQ, NVDA, FXI, XLP, and VWO.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
James S. Robertson - Chief Compliance Officer
Manager location
Houston, TX

Follow Filing Activity

Follow QCM Cayman, Ltd. and return when a new 13F portfolio filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q3 2024
Latest value
$3,632,666
Quarter delta
-$5,641,042
Accepted
04 Nov 2024, 16:36
Rows shown
1-25 of 44
Quarter Holdings SEC-reported value Bought Sold Net Top Holdings Form Type Accepted by SEC
Q3 2024 12 $3,632,666 +$2,729,771 -$8,302,256 -$5,572,485 SQQQ, NVDA, FXI, XLP, VWO 13F-HR 04 Nov 2024, 16:36
Q2 2024 36 $9,273,708 +$8,356,094 -$6,632,963 +$1,723,131 V, AMD, AZO, UBER, PANW 13F-HR 14 Aug 2024, 10:41
Q1 2024 21 $7,431,647 +$6,395,693 -$1,438,234 +$4,957,459 NVDA, SMCI, QQQ, AVGO, BKNG 13F-HR 08 May 2024, 16:06
Q4 2023 10 $1,854,743 +$904,432 -$14,542,924 -$13,638,492 TSLA, SOXX, QQQM, META, CMG 13F-HR 01 Feb 2024, 17:10
Q3 2023 64 $15,379,660 +$11,915,083 -$13,604,953 -$1,689,870 NVDA, BKNG, META, NVR, MSFT 13F-HR 30 Oct 2023, 16:37
Q2 2023 59 $17,011,359 +$12,247,895 -$11,751,314 +$496,581 BKNG, QQQ, CRM, AZO, MDB 13F-HR 25 Jul 2023, 16:59
Q1 2023 61 $15,969,860 +$13,218,541 -$4,577,154 +$8,641,387 QQQ, TSLA, MELI, IVV, MSFT 13F-HR 24 Apr 2023, 16:06
Q4 2022 37 $6,505,912 +$5,855,638 -$6,194,598 -$338,960 TSLA, MELI, COST, XLE, MDY 13F-HR 30 Jan 2023, 17:39
Q3 2022 39 $6,846,000 +$6,337,974 -$5,252,758 +$1,085,216 EWA, FXI, SPLG, ASML, REGN 13F-HR 10 Nov 2022, 16:02
Q2 2022 29 $5,781,000 +$3,873,349 -$20,302,469 -$16,429,120 EEM, EFA, VEA, MTD, TPTX 13F-HR 27 Jul 2022, 12:33
Q1 2022 85 $22,816,000 +$19,081,598 -$12,446,203 +$6,635,395 AMZN, GOOGL, FXI, BKNG, VEA 13F-HR 06 May 2022, 12:14
Q4 2021 74 $16,483,000 +$12,043,602 -$31,333,075 -$19,289,473 TSLA, BKNG, VEA, EEM, BND 13F-HR 11 Feb 2022, 16:28
Q3 2021 108 $36,038,000 +$27,168,390 -$28,905,747 -$1,737,357 IAU, EWJ, MDY, IJH, IEFA 13F-HR 01 Nov 2021, 17:22
Q2 2021 116 $38,693,000 +$27,951,789 -$22,920,474 +$5,031,315 SH, NOK, XLRE, EFA, IXUS 13F-HR 10 Aug 2021, 11:28
Q1 2021 108 $32,993,000 +$22,974,021 -$86,381,310 -$63,407,289 EEM, VEA, EWU, IYR, EWG 13F-HR 17 May 2021, 12:20
Q4 2020 271 $95,327,000 +$48,323,963 -$21,107,078 +$27,216,885 TSLA, NIO, SPLG, F, AMZN 13F-HR 12 Feb 2021, 08:59
Q3 2020 181 $57,383,000 +$28,125,934 -$18,431,476 +$9,694,458 TSLA, AMZN, BKNG, NIO, MDY 13F-HR 12 Nov 2020, 18:38
Q2 2020 141 $43,722,000 +$43,304,327 -$295,214 +$43,009,113 TSLA, BKNG, SLV, SPLG, XLF 13F-HR 14 Aug 2020, 12:46
Q1 2020 5 $584,000 +$457,000 -$5,111,424 -$4,654,424 XBI, F, M, KGC, AMLP 13F-HR 15 May 2020, 09:02
Q4 2019 26 $5,466,000 +$4,247,641 -$5,725,512 -$1,477,871 EEM, IEMG, F, SPY, AMZN 13F-HR 14 Feb 2020, 10:42
Q3 2019 37 $6,677,000 +$5,846,606 -$3,592,932 +$2,253,674 AMZN, NFLX, SBAC, ROKU, MRK 13F-HR 14 Nov 2019, 09:42
Q2 2019 31 $4,689,000 +$4,482,889 -$4,011,000 +$471,889 NFLX, CHK, XLU, ALGN, IAC 13F-HR 14 Aug 2019, 08:48
Q1 2019 38 $4,225,000 +$3,222,898 -$21,447,444 -$18,224,546 ACB, AMD, OSB, VFF, NTES 13F-HR 13 May 2019, 16:22
Q4 2018 122 $22,059,000 +$18,601,155 -$24,883,553 -$6,282,398 CAG, BABA, META, PBR, MSFT 13F-HR 14 Feb 2019, 14:41
Q3 2018 125 $29,870,000 +$27,764,765 -$18,626,570 +$9,138,195 ROKU, NMR, JD, CTSH, CGC 13F-HR 14 Nov 2018, 15:16
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .